Popular Trials
Nonsteroidal Anti-inflammatory Drug
Aspirin for Cancer
Recruiting4 awardsPhase 4
Birmingham, Alabama
This trial is testing if taking a small dose of aspirin regularly can help prevent cancer in elderly people in Australia and the US. Researchers will study blood, saliva, urine, and tumor samples to understand how aspirin might protect against cancer by looking at genes and biological markers. Aspirin has been widely studied and shown to have potential anti-cancer properties, particularly in preventing colorectal cancer.
Antiplatelet Agent
Clopidogrel +2 More for Coronary Artery Disease
Recruiting4 awardsPhase 4
Cleveland, Ohio
CYPRESS: A Prospective,Randomized,Multi-Center,Double-Blind Trial to Assess the Effectiveness and Safety of Different Durations of Dual Anti-Platelet Therapy (DAPT) in Subjects Undergoing Percutaneous Coronary Intervention with the CYPHER® Sirolimus-eluting Coronary Stent (CYPHER® Stent)
1 for Ototoxicity
Recruiting2 awards6 criteria
Toronto, Ontario
Aspirin (ASA) has been shown, in an animal model, to attenuate the ototoxic properties of cisplatin. The researchers plan to investigate this in patients undergoing cisplatin chemotherapy. The researchers hypothesise that low-dose aspirin can prevent cisplatin induced ototoxicity in the clinical setting.
Anticoagulant
Edoxaban for Atrial Fibrillation
Recruiting5 awardsPhase 4
La Jolla, California
This is a single arm, open label, single site study assessing the feasibility of post-procedural edoxaban therapy in atrial fibrillation (AF) patients after clinically indicated WATCHMAN left atrial appendage (LAA) closure.
Nonsteroidal Anti-inflammatory Drug
Aspirin for Acoustic Neuroma
Recruiting0 awardsPhase 2
Stanford, California
This trial is testing whether aspirin can slow tumor growth and improve hearing in patients aged 12+ with vestibular schwannomas. Aspirin's anti-inflammatory properties might help achieve these effects. Aspirin has been studied for its potential to protect against certain types of hearing loss and has shown some protective effects in previous studies.
Antiplatelet Agent
Ticagrelor +1 More for Thrombocytopenia
Recruiting3 awards4 criteria
Hamilton, Ontario
The specific objective of this study is to investigate the potential for normal platelets to reverse the inhibition of platelet aggregation in patients treated with ticagrelor in combination with aspirin.
Popular Filters
Phase 3 Trials
Nonsteroidal Anti-inflammatory Drug
Aspirin for Osteonecrosis of the Femoral Head
Recruiting3 awardsPhase 3
Montreal, Quebec
The purpose of this study is to determine if prolonged administration of low-dose aspirin will prevent the progression of early-stage osteonecrosis of the femoral head and may even reduce the extent of involvement of the femoral head by the necrotic process The design is intended to be parallel group where a total of 114 patients will be randomized in a 1:1 ratio to the treatment (ASA) and the control (Placebo) arms.
Anticoagulant
Apixaban vs Aspirin for Stroke Prevention in Atrial Fibrillation After Brain Bleed
Recruiting1 awardPhase 3
Birmingham, Alabama
This trial is testing whether apixaban is better than aspirin at preventing strokes or death in patients who have recently had a bleed in the brain and also have atrial fibrillation.
Anticoagulant
Rivaroxaban + Aspirin for Blood Clot Prevention After Joint Surgery
Recruiting4 awardsPhase 3
Halifax, Nova Scotia
This trial will test whether adding rivaroxaban to aspirin helps prevent venous thromboembolism better than aspirin alone in patients undergoing hip or knee replacement surgery.
Trials With No Placebo
Anticoagulant
Anticoagulation for Atrial Fibrillation Post-Ablation
Recruiting3 awardsPhase 4
Calgary, Alberta
This trial is comparing medical approaches for stroke prevention in people who have atrial fibrillation (AF) and have undergone a successful procedure called ablation to eliminate or substantially reduce the arrhythmia.
Diuretic
Hydrochlorothiazide +1 More for High Blood Pressure
Recruiting5 awardsPhase 4
Omaha, Nebraska
This will be a randomized, double-blinded, three-period crossover study of platelet activation and aggregation in 30 non-smoking healthy volunteers comparing chlorthalidone (CTD), hydrochlorothiazide (HCTZ), and aspirin (ASA; active control). The study hypothesis is that CTD has different effects on platelet activation and aggregation than HCTZ.
81mg aspirin for Postoperative Complications
Recruiting3 awards3 criteria
Chicago, Illinois
The purpose of this study is to determine whether aspirin taken in the perioperative period will increase the blood loss associated with open inguinal hernia repairs. A secondary purpose of this study is to determine if the aspirin administered in the perioperative period increases the risk of complications associated with open inguinal hernia repairs.
Local Anesthetic
Transthoracic Transversus Plane Block for Postoperative Pain
Recruiting3 awards1 criteria
London, Ontario
The TTP block is a novel regional anesthetic technique that shows promise in providing analgesia for anterior chest wall incisions and median sternotomy. The investigators hope to show that by providing the TTP block, there will be reduced early postoperative pain, reduced sedation and shallow breathing, reduced time on breathing machine, leading to an increase in patient comfort and satisfaction. The investigators also hope the decreased need for pain medication and reduced time on the breathing machine will translate into decreased nursing workload.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.